Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 3/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | RET | P07949 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7584485 | 0.78 | PIN1 (0.40) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL7584497 | 0.78 | PDPK1 (0.42) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL10492489 | 0.77 | ADRA1A (0.42) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL10492519 | 0.76 | ADRA1A (0.38) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL10492671 | 0.75 | IDO1 (0.40) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL2984209 | 0.71 | IDO1 (0.48) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL8849605 | 0.71 | DDB1 (0.53) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL78935 | 0.70 | IDO1 (0.44) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL8735629 | 0.69 | ADRA1A (0.46) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 | |
| SCHEMBL2905254 | 0.69 | ADRA1A (0.36) | IDO1PDPK1ADRA1ASIGMAR1CYP11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050197425-A1 | Thermosetting resin compositions, resin films and film articles | TAMURA KAKEN CORPORATION (JP) | 2005-09-08 | — | — | US | claimed |
| EP-4305681-A1 | NEW CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | CREDOXYS GmbH (DE) | 2024-01-17 | — | — | EP | disclosed |
| CN-116964026-A | Novel cerium (IV) complexes and their use in electronics | 克雷多西斯有限公司 | 2023-10-27 | — | — | CN | disclosed |
| US-20230092935-A1 | CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | Credoxys GmbH (DE) | 2023-03-23 | — | — | US | disclosed |
| WO-2022189431-A1 | NEW CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | Credoxys GmbH (DE) | 2022-09-15 | — | — | WO | disclosed |
| EP-4029069-A1 | CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | Credoxys GmbH c/o Institut for Applied Physics (DE) | 2022-07-20 | — | — | EP | disclosed |
| WO-2021048044-A1 | CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | Technische Universität Dresden (DE) | 2021-03-18 | — | — | WO | disclosed |
| EP-0467847-A1 | Polyarylene ether with tetraphenylethylene units | CIBA-GEIGY AG (CH) | 1992-01-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230092935-A1 | CERIUM (IV) COMPLEXES AND THEIR USE IN ORGANIC ELECTRONICS | CLIC4, KCNN4, CLN6 | IDO1 1159/4885PDPK1 3519/4885ADRA1A 3705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.